Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome
- M Trifa1,
- L Simon1,
- J Hamza1,
- F Bavoux2,
- N Burin des Roziers3
- 1Réanimation Pédiatrique, Hôpital Saint Vincent de Paul, 74 avenue Denfert-Rochereau, 75014 Paris, France
- 2Unité de pharmacovigilance, Hôpital Saint Vincent de Paul, 74 avenue Denfert-Rochereau, 75014 Paris, France
- 3Etablissement Français du Sang, Hôpital Saint Vincent de Paul, 74 avenue Denfert-Rochereau, 75014 Paris, France.
- Correspondence to:
Dr J Hamza, Service d’Anesthésie-Réanimation Pédiatrique, Hôpital Saint-Vincent de Paul, 74–82, avenue Denfert Rochereau, 75014 Paris, France;
j.hamza{at}svp.ap-hop-paris.fr
We report a case of severe haemolysis in a patient who received high dose immunoglobulin therapy. A 4 year old, 16 kg boy, with AB Rhesus positive blood, was admitted to our intensive care unit with Guillain-Barré syndrome. Rapid progression to respiratory failure and abnormal deglutition were observed. Mechanical ventilation had to be initiated a few hours …
